Apigenin could suppress the m-TOR/PI3K/Akt signaling pathway to induce its anti-cancer potential in drug-resistant colon cancer cells, suggesting that apigenin could be a potential chemo-sensitizer to cisplatin in CRC cells [200]. Here, AKT1 is linked to colonic neoplasm.